VOYA Investment Management’s Precision BioSciences DTIL Stock Holding History

VOYA Investment Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-732	Closed	-$68K	–	2807
2022 Q1	$68K	Buy	732 +97	+15%	+$13.2K	﹤0.01%	2562
2021 Q4	$141K	Buy	635 +6	+1%	+$1.68K	﹤0.01%	2603
2021 Q3	$218K	Hold	629	–	–	﹤0.01%	2519
2021 Q2	$236K	Sell	629 -83	-12%	-$24.9K	﹤0.01%	2512
2021 Q1	$221K	Buy	712 +39	+6%	+$13.7K	﹤0.01%	2486
2020 Q4	$168K	Buy	673 +130	+24%	+$31.9K	﹤0.01%	2471
2020 Q3	$100K	Hold	543	–	–	﹤0.01%	2341
2020 Q2	$136K	Sell	543 -42	-7%	-$9.2K	﹤0.01%	2276
2020 Q1	$106K	Hold	585	–	–	﹤0.01%	2327
2019 Q4	$244K	Buy	+585	New	+$184K	﹤0.01%	2281

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VOYA Investment Management's DTIL Position: Q2 2022 in Review

VOYA Investment Management sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 732 shares — an estimated $68K sold.

VOYA Investment Management first reported a position in DTIL in Q4 2019 and held it in 10 quarters. The position peaked at $244K in Q4 2019. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

VOYA Investment Management reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
VOYA Investment Management sold 732 Precision BioSciences shares in Q2 2022, an estimated $68K.
VOYA Investment Management first reported a position in Precision BioSciences in Q4 2019 and held it in 10 quarters.
VOYA Investment Management's Precision BioSciences position peaked at $244K in Q4 2019.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.